Quarterly figures: Evonik increases operating profit and emphasizes independence
The chemical group emerges stronger from the third quarter. Chief Financial Officer Rauch advocates for the group's independence - and criticizes the timing of BASF's takeover offer.
Evonik, a chemical company based in Essen, has sent a clear message to competitor BASF, which is interested in acquiring the company. Evonik's CFO, Michael Rauch, stated that the company is strong and can achieve growth on its own, citing the company's improved quarterly results. In Q3, Evonik's adjusted operating profit rose 40% to €629 million and revenue increased 13% to €3.8 billion.
The company has upgraded its outlook for the full year, with interim CEO Claus Rettig emphasizing Evonik's strength and robustness. Despite this, Evonik reported a loss of €53 million, partly due to restructuring costs.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
